Arrowstreet Capital Limited Partnership Purchases 247,118 Shares of Option Care Health, Inc. $OPCH

Arrowstreet Capital Limited Partnership increased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 6.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 4,248,425 shares of the company’s stock after buying an additional 247,118 shares during the quarter. Arrowstreet Capital Limited Partnership’s holdings in Option Care Health were worth $135,355,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. V Square Quantitative Management LLC bought a new position in shares of Option Care Health during the fourth quarter worth about $25,000. Advisory Services Network LLC acquired a new position in Option Care Health during the third quarter valued at approximately $35,000. McIlrath & Eck LLC acquired a new position in Option Care Health during the second quarter valued at approximately $37,000. Caitong International Asset Management Co. Ltd acquired a new position in Option Care Health during the third quarter valued at approximately $38,000. Finally, Quarry LP boosted its position in Option Care Health by 502.7% during the third quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after purchasing an additional 1,292 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO John Charles Rademacher acquired 12,500 shares of the stock in a transaction on Monday, May 4th. The shares were purchased at an average price of $21.18 per share, for a total transaction of $264,750.00. Following the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at approximately $14,723,319.36. The trade was a 1.83% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,610 shares of the stock in a transaction on Monday, May 4th. The shares were bought at an average price of $21.41 per share, for a total transaction of $783,820.10. Following the purchase, the director owned 450,000 shares in the company, valued at approximately $9,634,500. This trade represents a 8.86% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have purchased a total of 73,264 shares of company stock worth $1,548,316 in the last 90 days. Company insiders own 1.70% of the company’s stock.

Option Care Health Price Performance

Option Care Health stock opened at $21.23 on Tuesday. The stock’s fifty day moving average price is $23.57 and its two-hundred day moving average price is $29.19. Option Care Health, Inc. has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The firm has a market cap of $3.33 billion, a PE ratio of 16.46, a price-to-earnings-growth ratio of 1.15 and a beta of 0.67.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Thursday, April 30th. The company reported $0.40 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The firm had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter last year, the company earned $0.40 EPS. The company’s revenue was up 1.3% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. As a group, research analysts expect that Option Care Health, Inc. will post 1.64 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts recently commented on OPCH shares. Barrington Research reduced their price target on Option Care Health from $42.00 to $32.00 and set an “outperform” rating for the company in a research report on Friday, May 1st. Truist Financial set a $30.00 price target on Option Care Health in a research report on Friday, May 1st. Weiss Ratings cut Option Care Health from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Morgan Stanley set a $28.00 price objective on Option Care Health in a research report on Wednesday, May 6th. Finally, Zacks Research cut Option Care Health from a “hold” rating to a “strong sell” rating in a research report on Monday, May 11th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $30.54.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.